Pasadena Research Labs
Executive Summary
Former Lyphomed Chief Operating Officer Floyd Benjamin acquires an interest in the San Clemente, Calif.-based firm and assumes the title of partner of scientific affairs, responsible for science and regulatory issues, the company reports. Pasadena Research Labs describes itself as a provider of "specialty injectable drugs to hospitals and physicians, with an emphasis on sourcing hard-to-find products." Benjamin most recently was president and CEO of the Irvine, Calif.-based biotech firm Neocrine.